Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insiders Cut Stakes in Standex Int’l Corp. (SXI) and Mead Johnson Nutrition CO (MJN)

Page 1 of 2

Insider are privy to a lot of information about their companies than individual investors and even institutional investors. When insider sell shares, other investors usually see it as a bearish sign, however, that’s not always the case. There can be various reasons because of which an insider might sell his or her shares like for profit booking purposes or for funding an expense. Nevertheless, it’s always beneficial for an investor to keep track of what insiders in a company are doing with their stakes. In this article we will be focusing on two companies in which insiders have sold their shares recently: Standex Int’l Corp. (NYSE:SXI), and Mead Johnson Nutrition CO (NYSE:MJN).

Raj Rajaratnam thinking

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 118% over the ensuing 36 months, outperforming the S&P 500 Index by nearly 60 percentage points (read more details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Let’s start with Standex Int’l Corp. (NYSE:SXI), a New Hampshire-based manufacturer of services and products for different types of industrial and commercial market segments. Thomas D. DeByle, the Vice President, Treasurer, and Chief Financial Officer of the company since 2008, reported selling 212 and 3,400 shares of the company on August 31 and September 1 respectively, at an average price of $81.02 per share. Following these transactions, Mr. DeByle owns 40,037 shares of Standex Int’l Corp. (NYSE:SXI). After witnessing a gradual uptrend after the financial crisis, the company’s stock has remained relatively range-bound since May 2014 and are currently trading down by 2.4% year-to-date. Standex Int’l Corp. (NYSE:SXI)’s stock jumped by nearly 10% on August 25 on the back of better-than-expected earnings of $1.31 per share, compared to estimates of $1.26. Following the financial results, Wunderlich Securities  reiterated its ‘Buy’ rating on the stock and raised the price target to $98 from $92. Among the funds we track Cliff Asness’s AQR Capital Management and Mario Gabelli‘s GAMCO Investors were the top two shareholders of Standex Int’l Corp. (NYSE:SXI) at end of June, owning 95,237 shares and 74,400 shares respectively.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!